Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft Patency”

521 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 521 results

Post-approval studies (Phase 4)Study completedNCT02446522
What this trial is testing

Compare Endoscopic and Open Methods of Vein Harvesting for Coronary Artery Bypass Grafting

Who this might be right for
Autovenous Conduit for Coronary Artery Bypass Grafting
Meshalkin Research Institute of Pathology of Circulation 228
Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Large-scale testing (Phase 3)Study completedNCT00330772
What this trial is testing

Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study

Who this might be right for
Coronary Artery DiseaseCoronary Artery Bypass Grafting
Hamilton Health Sciences Corporation 150
Not applicableActive Not RecruitingNCT03126409
What this trial is testing

No-Touch Versus Conventional Saphenous Vein Harvesting Technique

Who this might be right for
Coronary Artery Disease
China National Center for Cardiovascular Diseases 2,655
Early research (Phase 1)Study completedNCT02923375
What this trial is testing

CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Cynata Therapeutics Limited 16
Large-scale testing (Phase 3)Study completedNCT02639247
What this trial is testing

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 333
Testing effectiveness (Phase 2)Looking for participantsNCT07630727
What this trial is testing

Study of AHB-171 in Chronic Hepatitis B Participants

Who this might be right for
Hepatitis B, Chronic (CHB)
Ausper Biopharma Co., Ltd. 138
Post-approval studies (Phase 4)Study completedNCT00044720
What this trial is testing

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Who this might be right for
Chronic Kidney FailureGraft vs Host DiseaseKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 484
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Testing effectiveness (Phase 2)Study completedNCT00136396
What this trial is testing

Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Dana-Farber Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT00693381
What this trial is testing

Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 152
Post-approval studies (Phase 4)Ended earlyNCT00617279
What this trial is testing

GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft

Who this might be right for
Peripheral Arterial Occlusive Disease
W.L.Gore & Associates 31
Testing effectiveness (Phase 2)Study completedNCT01422772
What this trial is testing

Safety Study of Gene Therapy for Ischemic Heart Disease in Korea

Who this might be right for
Ischemic Heart Disease
Helixmith Co., Ltd. 9
Not applicableStudy completedNCT03717259
What this trial is testing

Recovery of Short-term Renal Function in Post-transplant Patients Living Donor

Who this might be right for
Nephrectomy
Instituto Mexicano del Seguro Social 508
Large-scale testing (Phase 3)UnknownNCT04289103
What this trial is testing

Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD

Who this might be right for
Steroid Refractory GVHD
ElsaLys Biotech 65
Not applicableUnknownNCT02173860
What this trial is testing

Strategies for Revascularization in Patients Undergoing Heart Valve Surgery With Concomitant Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseValvular Heart Disease
Portuguese Society of Cardiology 502
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Not applicableLooking for participantsNCT06895070
What this trial is testing

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

Who this might be right for
Heart TransplantHeart FailureTransplant; Failure, Heart
XVIVO Perfusion 60
Early research (Phase 1)Study completedNCT03497273
What this trial is testing

Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

Who this might be right for
Acute Graft-versus-host Disease
Incyte Corporation 14
Not applicableStudy completedNCT00786942
What this trial is testing

Bone Graft Necessity in Opening-Wedge High Tibial Osteotomy

Who this might be right for
Osteoarthritis
University of Campinas, Brazil 44
Next Page